tldrdailynews.com logo
Tag

Hair Loss

All articles tagged with #hair loss

Men Embrace Aesthetics to Align Look with How They Feel
health2 days ago

Men Embrace Aesthetics to Align Look with How They Feel

As stigma fades, more men seek cosmetic and aesthetic treatments not to chase youth but to harmonize their appearance with their self-image; about 15% of cosmetic procedures are performed on men. Treatments range from Botox and lasers to surgical options, but experts caution that non-surgical interventions carry risks if overdone. Foundational steps before pursuing procedures include quitting nicotine, sticking to a simple skincare routine (daily sunscreen and retinoids), maintaining a healthy weight, addressing hair loss early with FDA-approved therapies like finasteride and minoxidil, and staying physically active to support overall health and appearance.

via Fox News|
#aesthetic-treatments#cosmetic-surgery#hair-loss
Tirzepatide Might Trigger More Hair Loss Than Semaglutide, Early Study Suggests
health6 days ago

Tirzepatide Might Trigger More Hair Loss Than Semaglutide, Early Study Suggests

A preprint study comparing tirzepatide (Zepbound/Mounjaro) with semaglutide (Ozempic/Wegovy) in 8,985 women found higher incident alopecia with tirzepatide (5.44% vs 3.63%). At six months, 1.55% vs 1.24%; at twelve months, 4.20% vs 2.88%. After adjusting for weight loss, hair loss remained more common with tirzepatide (4.24% vs 3.33%), suggesting weight loss alone doesn’t explain the difference. The study is observational and not yet peer‑reviewed. Experts note GLP-1 meds can cause temporary shedding, and persistent patches should be evaluated by a dermatologist; patients should not stop their medication without physician guidance. The differing receptor targets (GIP/GLP-1 for tirzepatide vs GLP-1 alone for semaglutide) may influence the hair follicle environment, but mechanisms are not yet clear.

via Women's Health|
#alopecia#glp-1#hair-loss
Liquid Hair Growth Vitamin Hits Deep Discount, Rave-Reviewed for GLP-1-Related Hair Loss
shopping6 days ago

Liquid Hair Growth Vitamin Hits Deep Discount, Rave-Reviewed for GLP-1-Related Hair Loss

Amid reports that GLP-1 weight-loss meds can cause hair shedding, HuffPost Shopping spotlights MaryRuth’s Liquid Hair Growth Multivitamin as a widely praised, multi-benefit vitamin that reviewers say helps hair, nails, and skin; it’s on sale on Amazon (as low as $17 for an 8-pack or $56 for a 30‑oz bottle), with others noting improvements in hair fullness and strength.

via HuffPost|
#biotin#hair-growth#hair-loss
Ozempic Hair: Why rapid weight loss from GLP-1 drugs can trigger shedding
health20 days ago

Ozempic Hair: Why rapid weight loss from GLP-1 drugs can trigger shedding

Ozempic hair describes the hair shedding seen after rapid weight loss on GLP-1 drugs such as Ozempic, Wegovy, and Mounjaro. Doctors say the shedding is usually not caused directly by the drug but by rapid weight loss and related nutritional gaps including protein, iron, zinc, vitamin D and B vitamins, which can disrupt the hair growth cycle known as telogen effluvium. Symptoms include more hair on pillows, in brushes, and during washing, especially with very rapid weight loss or extreme calorie restriction. The shedding is typically temporary and improves as weight stabilizes and nutrition improves. To reduce risk, aim for gradual weight loss, ensure adequate protein and micronutrients, avoid crash diets, and consult a dermatologist if shedding persists or bald patches appear.

via NDTV|
#glp-1#hair-loss#health
Unpacking Side Effects of GLP-1 Weight-Loss Drugs
health29 days ago

Unpacking Side Effects of GLP-1 Weight-Loss Drugs

The piece surveys reported side effects of GLP-1 weight-loss drugs (like Wegovy and Mounjaro), noting that digestive issues such as nausea and diarrhea are well-documented, eye problems appear rare but possible, and pregnancy-related considerations remain uncertain. It highlights 'Ozempic face' and hair thinning as widely discussed side effects, with hair loss potentially tied to rapid weight loss and nutritional changes rather than the drugs alone. Overall, evidence varies by side effect, and more research is needed to confirm causal relationships and reversibility.

via The Guardian|
#glp-1-medications#hair-loss#health
GLP-1 Meds May Trigger Rare Hair Loss, Study Finds
health1 month ago

GLP-1 Meds May Trigger Rare Hair Loss, Study Finds

A BMJ study links GLP-1 diabetes/weight‑loss meds (semaglutide and tirzepatide) to a small but higher risk of non-scarring hair loss (alopecia) compared with SGLT-2 or DPP-4 therapies. After roughly 2.7 years, GLP-1 users had about 37% higher odds than SGLT-2 and 68% higher than DPP-4, with absolute rates of about 3–9 cases per 1,000 people per year. Hair shedding is usually non-permanent and may reflect telogen effluvium triggered by rapid weight loss or nutrient gaps; while the benefits of GLP-1 drugs remain substantial, patients should be aware of this potential trade-off and monitor for hair changes.

via The Daily Beast|
#alopecia#glp-1#hair-loss
Hair-loss risk linked to GLP-1 weight-loss drugs in large study
science1 month ago

Hair-loss risk linked to GLP-1 weight-loss drugs in large study

A BMJ study of about 50,000 patients finds that GLP-1 receptor agonists used for diabetes and obesity (Mounjaro, Wegovy, Ozempic) are linked to a higher risk of hair loss than other diabetes meds, with a 37% higher risk vs SGLT-2 inhibitors and 68% higher vs DPP-4 inhibitors; most hair loss is non-scarring and may relate to weight loss/caloric restriction and micronutrient changes, though regulators are reviewing safety signals; hair loss is usually not physically harmful but can affect quality of life.

via The Independent|
#alopecia#diabetes#glp-1-receptor-agonists
GLP-1 Weight-Loss Drugs Show Small, Reversible Link to Hair Loss
health1 month ago

GLP-1 Weight-Loss Drugs Show Small, Reversible Link to Hair Loss

A BMJ study of electronic health records finds GLP-1 receptor agonists, used for type 2 diabetes and obesity, are associated with a higher but still rare risk of alopecia compared with SGLT-2 and DPP-4 inhibitors; most cases are reversible as hair follicles remain intact; rapid weight loss and nutritional factors may contribute; the risk could affect patient satisfaction and adherence, and more research is needed to understand mechanisms and identify who is at greatest risk.

via Euronews.com|
#alopecia#diabetes#glp-1
GLP-1 Weight-Loss Drugs May Bring Tiny Hair-Loss Risk
health1 month ago

GLP-1 Weight-Loss Drugs May Bring Tiny Hair-Loss Risk

A Penn Medicine study of about 12,000 adults with type 2 diabetes newly started on GLP-1 drugs (including Ozempic and tirzepatide) found a small but higher risk of alopecia compared with users of other diabetes meds—about 1.6% developed hair loss over roughly two to three years, with GLP-1 users 37% more likely than SGLT-2 inhibitors and 68% more likely than DPP-4 inhibitors. The effect is mainly non-scarring and may be reversible; weight loss and possible nutrient deficiencies (iron, zinc) could drive a telogen effluvium mechanism. The study is observational and cannot prove causation; FDA labeling already lists alopecia as a potential adverse reaction, and ongoing dermatologic surveillance is advised.

via Gizmodo|
#alopecia#glp-1s#hair-loss
Hair loss linked to GLP-1 weight-loss drugs in new study
science1 month ago

Hair loss linked to GLP-1 weight-loss drugs in new study

A BMJ study of about 50,000 people finds GLP-1 receptor agonists (used for diabetes and obesity, including Wegovy, Ozempic and Mounjaro) are associated with a higher risk of hair loss compared with other diabetes drugs; after adjustment, risk was 37% higher than SGLT-2 inhibitors and 68% higher than DPP-4 inhibitors, with indications that the hair loss is non-scarring and may relate to weight loss, micronutrient deficiencies, or hormonal changes; regulators are reviewing safety signals.

via The Independent|
#glp-1#hair-loss#mounjaro
New Study Flags Hair Loss Risk with GLP-1 Drugs
health1 month ago

New Study Flags Hair Loss Risk with GLP-1 Drugs

A BMJ study led by the University of Pennsylvania finds that GLP-1 receptor agonists used for obesity and type 2 diabetes are linked to a higher risk of non-scarring hair loss compared with SGLT-2 and DPP-4 inhibitors, though the absolute risk is small (about 7 in 1,000 per year). The researchers suggest rapid weight loss and nutritional changes as potential mechanisms and call for more research, while noting the need to weigh this potential side effect against the drugs’ benefits in shared decision-making.

via ScienceAlert|
#alopecia#bmj-study#glp-1-receptor-agonists
From Shaved Head to Chemo Curls: A Survivor’s Hair Regrowth Story
lifestyle1 month ago

From Shaved Head to Chemo Curls: A Survivor’s Hair Regrowth Story

A UK breast cancer survivor, Chloe Williams, shared on Instagram how chemotherapy caused hair and eyelash loss but eventually led to regrowth with distinctive curls, documenting the journey from shaving her head to embracing her hair’s new texture and style, and offering hope to others; WHO data note 694,000 breast cancer deaths globally in 2024 and that it was the most common cancer in women in 164 of 186 countries.

via NDTV|
#breast-cancer#chemo-curls#chemotherapy
Early Balding Linked to Lower Prostate Cancer Risk
health1 month ago

Early Balding Linked to Lower Prostate Cancer Risk

A study of men aged 35–76 found that those who began balding by age 30 had a 29% lower risk of developing prostate cancer, and those who started balding even earlier had a 45% lower risk for both aggressive and less aggressive forms, possibly due to a shared genetic variant in the androgen receptor gene; however, prior research has yielded mixed results, with some studies linking baldness to higher risk of fatal prostate cancer. The exact mechanism remains unclear, and cancer screening guidance remains age-based (start at 40 for higher risk; general screening commonly begins at 55–69).

via New York Post|
#androgen-pathway#genetics#hair-loss